Pharmaceutical Sales Representative in France: Portrait of a Field Job Under Pressure

The French market accounts for over 20,242 pharmacies, distributed across metropolitan and overseas territories, according to the National Chamber of Pharmacists (Ordre National des Pharmaciens). Behind every product shelf and display, the pharmaceutical representative provides the daily connection between laboratories, brands, and healthcare professionals. This profession operates within a strict regulatory framework, particularly when it comes to products subject to specific promotional guidelines.

This is a sector undergoing full transformation. Field CRM, route optimization, and data collection tools are multiplying, but their actual adoption often remains poorly measured by companies themselves. In this context, recruitment and retention challenges are intensifying, making a better understanding of the realities experienced by reps in the field essential.

At Sidely, we support healthcare sales teams on a daily basis through our mobile CRM, and we noticed that the pharmaceutical representative profession remained poorly documented by updated, quantitative data, despite the rapid shifts it is going through. Therefore, to paint an accurate picture, Sidely gathered their feedback between March and May 2026, on topics ranging from daily field organization to the use of artificial intelligence, as well as compensation and the tools used.

This article presents the major trends of this study: the actual pace of the job, the tools they use, the question of compensation, and the emerging role of artificial intelligence.

A field job saturated even before starting

An almost daily presence in the field

The pharmaceutical representative remains a profession of intense physical presence. According to the study, 95.3% of representatives are in the field every day, with the rare exceptions concerning senior profiles positioned on specific channels, notably healthcare facilities. This consistency confirms that the job is primarily based on a continuous coverage of the territory.

Mileage, visits, and actual time spent in the field

On average, a pharmaceutical representative travels 1,045 kilometers per week, which is approximately 52,000 kilometers per year. However, this average hides very marked geographic disparities: a representative in Île-de-France travels an average of 481 kilometers per week, compared to 1,333 kilometers in Pays de la Loire, illustrating how much the same job title can cover very different field realities.

Added to this is an average of five visits per day, each lasting over an hour. Adding travel and visits, a representative's actual day exceeds seven hours of pure field time, even before accounting for time spent on administrative tasks. This compression of available time is not temporary: it constitutes a structural characteristic of the profession in 2026.

Admin work, the primary friction point of the profession

When asked in an open question what they would like to improve as a priority, representatives cite administrative workload ahead of pressure from targets, with 29.1% of mentions. This result is not surprising: it reflects the fact that representatives have learned, over time, to deal with mileage and sales pressure, but still struggle to absorb the growing bureaucratization of their profession.

This finding is coupled with an interesting paradox. While 70.8% of representatives have a CRM, 40.6% of them find it time-consuming. The equipment exists, then, but is not always enough to streamline daily operations. A potential solution to this paradox lies in artificial intelligence, as shown in the rest of this article: among representatives who already use it, administrative burden has purely and simply disappeared from the list of their main difficulties.

Compensation and attractiveness of the profession

What a pharmaceutical representative earns in 2026

Compensation is a central issue for a job that relies on high field availability. While average levels vary depending on the type of employer, the 2026 Sidely study confirms that pharmaceutical laboratories generally pay their representatives better than outsourced agencies, with an average total compensation of 66,600 euros compared to 44,200 euros—a 51% gap across both base salary and variable pay components.

Why compensation is not enough to retain talent

Despite these compensation levels, the attractiveness of the profession remains fragile. The size of the employing organization strongly influences both salary levels and the overall perception of the position, while the geographic differences observed in mileage are also reflected, to a lesser extent, in regional pay scales.

These elements confirm that the salary variable alone is not enough to retain the most experienced representatives, in a context where more than a third of the market is considering career mobility in the short term.

What tools do pharmaceutical representatives have (and lack)?

Order taking and CRM: the two cornerstone tools of the profession

Two tools largely dominate the equipment of pharmaceutical representatives, regardless of the size of their organization: the order-taking tool, used by 71.7% of respondents, and the CRM or SFA, used by 70.8% of them.

Beyond this shared foundation, equipment rates drop quickly: territory mapping tools only concern 25.5% of representatives, and route planning tools only 23.6%.

Route optimization, the most profitable and least deployed tool

The most striking contrast concerns the route optimization tool.

Only 12.3% of representatives have one, even though, according to the study, it is identified as the most profitable tool among all measured equipment. The mileage difference between equipped and non-equipped representatives reaches over 1,200 kilometers per week, a gap too significant to remain ignored by sales directors and HR teams in the medium term.

No single device wins on all fronts

In terms of hardware, the choice between smartphone, tablet, and computer is not just a matter of individual preference. The smartphone proves to be more effective during visits, with a shorter processing time than on a computer, but the tablet maintains an advantage for planning times. This complementarity suggests that field performance depends less on a single device than on a coherent combination of tools tailored to each step of the representative's day.

Discover how to leverage your sales CRM as a pharmaceutical representative.

AI, spontaneous adoption but without a framework

80% of representatives do not use AI yet, but believe in it

Artificial intelligence remains, at this stage, a minority tool in the daily life of pharmaceutical representatives: 80.2% of them do not use it yet, and 85.8% have received no training on the subject. However, 73.5% of respondents believe in the potential of artificial intelligence to improve their field efficiency. This mismatch between belief and actual usage reflects an unmet expectation that companies in the sector would do well to address quickly.

Individual use in a highly regulated sector

Among representatives who already use artificial intelligence, 57% do so without a framework defined by their company, or even as part of a strictly individual approach. This finding raises a real compliance issue in a sector as regulated as pharmaceuticals, where obligations related to the promotion of healthcare products are particularly strict. Above all, it reveals that companies are lagging behind in structuring their policy on the use of artificial intelligence in the field, while representatives are not waiting and are already experimenting on their own.

In fact, the most frequent use relates to writing reports, exactly where the administrative workload weighs heaviest on a daily basis. Early adopters have thus spontaneously resolved their main friction point, without waiting for directives or a formal framework from their company.

The pharmaceutical representative profession in 2026 remains primarily one of intense field presence, with a compression of available time that is becoming structural rather than temporary. Administrative workload stands out as the primary daily friction point, ahead of target pressure, and existing tools, although widely deployed in terms of CRM and order taking, are not always enough to solve this problem.

The gap in equipping teams with route optimization solutions illustrates how much certain high-impact tools remain underutilized by the majority of organizations. Artificial intelligence, for its part, is already beginning to fill this gap for representatives who use it, particularly regarding administrative workload, but its adoption remains largely individual and unguided by companies, in a sector where regulatory compliance should nevertheless encourage caution.

This article presents only a portion of the insights from the 2026 Sidely study on pharmaceutical representatives. The complete study details, in particular, the compensation gaps by region and seniority, as well as the precise profiles of artificial intelligence users according to the size of their organization.

Download the complete study to discover all the data on the pharmaceutical representative profession.